Biotech Startups

Human Biome develops next-generation biotherapeutics aimed at treating diseases and restoring health by strengthening the body's natural barriers. The company focuses on microbiome-based therapeutic approaches.

1 investor

1 investor

The Human Phenotype Project, powered by Pheno.AI, is a longitudinal multi-omic study that deeply profiles participants across multiple countries over 25 years to build research-ready health datasets. It provides these datasets and an end-to-end cohort-building solution to universities and research institutions working in healthcare, life sciences, and pharma.

1 investor

Humanity Neurotech works on biophysics research aimed at improving human health.

1 investor

Humasis develops and manufactures in-vitro diagnostic medical devices, producing 163 product items through its central R&D lab focused on diagnostic source technologies. Founded in 2000, the South Korean company exports its diagnostic products to 74 countries.

1 investor

Hummsa Biotech develops oral small molecule therapeutics targeting chronic metabolic diseases through multi-targeted approaches, aiming to shift treatment from reactive to preventive and regenerative care. The company prioritizes affordability and accessibility across global markets.

1 investor

Suzhou Huihan Medical Technology Development develops and applies biosurgical products for wound repair, orthopedic implants, and tissue engineering, offering surgeons products across hemostasis, surgical sealing, anti-adhesion, and soft tissue management. Founded in 2005, it builds on five proprietary technology platforms—colloidal silver, hydrogel, bacterial cellulose, bio-3D, and metallothionein—and holds over 50 medical device registrations in China.

1 investor

Guangdong Hybribio Biotech is a Chinese developer and supplier of nucleic acid molecular diagnostic products, focused on the R&D, production, and sale of molecular diagnostic reagents and instruments, including HPV genotyping detection kits and gene chips. The company also operates a healthcare arm, including a specialty hospital in Chaozhou offering blood purification, health screening, and chronic disease management services.

1 investor

Hydronovo develops regenerative therapies based on stem cell reactivation, with an initial treatment aimed at repairing damaged salivary glands to address xerostomia (chronic dry mouth).

1 investor

Hyrax Biosciences develops Exatype, a DNA sequence analysis software platform that performs genotyping, quality control, reference mapping, and mutation calling for pathogens including HIV, TB, SARS-CoV-2, and cancer. It serves assay and instrument manufacturers, laboratories, pharmaceutical companies, clinical trial organizations, and research institutions.

1 investor

Intrinsic Foundries engineers biological systems to convert carbon emissions into valuable feedstock, targeting industrial sectors where carbon is generated in high volumes. The company applies synthetic biology and bioengineering to transform waste carbon into wealth at scale.

1 investor

Ikonopedia provides a breast imaging software platform for radiologists and patients, featuring structured reporting tools, risk assessment, and closed-loop lesion tracking to ensure comprehensive breast health management and follow-up care.

1 investor

i-Lumen Scientific develops a non-invasive bioelectric therapy aimed at restoring retinal electrophysiology in patients with intermediate to advanced dry age-related macular degeneration (AMD). The company targets vision loss in adults by supporting the eye's retinal pigment epithelium and transepithelial potential.

1 investor

i2020 Accelerator (T123 LLC) is a drug discovery accelerator that de-risks early-stage science and advances drug discovery platforms toward lead and clinical candidate stage within roughly two years, working across therapeutic areas such as oncology, immunology, and infectious diseases. It co-creates and invests in biotech startups, operating as part of the Expert Systems integrated accelerator platform.</parameter> <parameter name="hq_city">San Diego

1 investor

i3 Membrane develops coated polymer membranes and porous films with adjustable electrical conductivity for separation and purification tasks, including sterile filtration for infection prevention, particle analysis (microplastics, asbestos), and digital membrane chromatography. Its technology targets laboratory/pharma, biotech, and medical technology customers.

1 investor

Fluidics designs and manufactures customized microparticles and capsules for businesses requiring specialized formulations, leveraging in-house capabilities for active protection, controlled release, and formulation enhancement.

1 investor

IBI SA (Industrie Biomediche Insubri SA) researches, develops, and produces medical devices for tissue engineering and regenerative medicine, including bone substitutes, grafts, 3D matrixes, and 2D scaffolds.

1 investor

ICBII develops molecular technology platforms designed to deliver therapeutic molecules across the blood-brain barrier to treat neurodegenerative diseases such as Parkinson's and Alzheimer's. The company focuses on advancing drug delivery capabilities for treating major diseases affecting the central nervous system.

1 investor

Ickler Electric is an electrical contracting firm with 35 years of experience serving the biotech, electronics, and mission-critical industries. The company performs complex electrical construction and installation projects with in-house engineering, CAD/BIM design, prefabrication, and service capabilities.

1 investor

Icon Bioscience develops biodegradable, sustained-release intraocular ophthalmic products using its proprietary Verisome drug delivery technology, targeting unmet needs in inflammation, glaucoma, and retinal disease treatment.

1 investor

Iconovo develops advanced inhaler platforms and dry powder formulations optimized together to deliver medicines through inhalation across multiple therapeutic areas. The company partners with pharmaceutical manufacturers to create effective alternatives to tablets and injections, generating revenue through development partnerships, milestone payments, and royalties.

1 investor

ICON plc is a global Contract Research Organization providing consulting and outsourced development services to pharmaceutical, biotechnology, medical device, and government organizations to accelerate drug and device development. The company supports clients across all phases of clinical development with integrated services spanning study design, patient recruitment, digital trial solutions, and commercialization.

1 investor

IdentiGEN (part of MSD Animal Health) offers technology that combines DNA and data intelligence to provide traceability and lifecycle insights across the animal and food supply chain. It serves food companies, retailers, processors, veterinarians, nutritionists, genetics companies, farm groups, and government bodies.

1 investor

iDose TR is a procedural pharmaceutical implant that delivers travoprost therapy to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The implant uses a proprietary membrane with nanoporous material for controlled drug delivery as an alternative to daily eye drops.

1 investor